WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain.
Journal
JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
18
06
2020
accepted:
03
09
2020
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
epublish
Résumé
To analyse by WGS the ceftolozane/tazobactam (C/T) resistance mechanisms in The clonal relatedness, the resistome and the virulome of 45 In Prediction of antimicrobial susceptibility profiles using WGS is challenging. Carbapenemase-encoding genes are associated with C/T resistance in
Identifiants
pubmed: 34223039
doi: 10.1093/jacamr/dlaa084
pii: dlaa084
pmc: PMC8210196
doi:
Types de publication
Journal Article
Langues
eng
Pagination
dlaa084Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
Références
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Int J Antimicrob Agents. 2009 Aug;34(2):173-6
pubmed: 19464856
J Antimicrob Chemother. 2017 Aug 1;72(8):2145-2155
pubmed: 28541467
J Clin Microbiol. 2019 Feb 27;57(3):
pubmed: 30381421
Clin Infect Dis. 2016 Jul 15;63(2):234-41
pubmed: 27098166
Microb Genom. 2020 Feb;6(2):
pubmed: 32048983
mBio. 2016 Apr 26;7(2):e00347-16
pubmed: 27118589
Int J Antimicrob Agents. 2019 May;53(5):682-688
pubmed: 30769199
mSphere. 2020 Apr 8;5(2):
pubmed: 32269151
Clin Microbiol Rev. 2019 Nov 13;33(1):
pubmed: 31722889
Genome Biol. 2016 Jun 20;17(1):132
pubmed: 27323842
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Int J Antimicrob Agents. 2015 Jul;46(1):111-6
pubmed: 25914088
Int J Antimicrob Agents. 2018 Jul;52(1):100-103
pubmed: 29580930
Clin Microbiol Infect. 2015 Feb;21(2):148.e1-4
pubmed: 25596781
J Antimicrob Chemother. 2013 Oct;68(10):2234-44
pubmed: 23722448
Euro Surveill. 2008 Nov 20;13(47):
pubmed: 19021958
J Antimicrob Chemother. 2012 Jul;67(7):1597-606
pubmed: 22499996
Drugs. 2019 Sep;79(14):1529-1541
pubmed: 31407238
J Antimicrob Chemother. 2019 Jul 1;74(7):1934-1939
pubmed: 31225611
EClinicalMedicine. 2019 Oct 17;15:72-79
pubmed: 31709416
Microb Genom. 2018 Jul;4(7):
pubmed: 29916797
J Antimicrob Chemother. 2014 Oct;69(10):2713-22
pubmed: 24917579
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
J Antimicrob Chemother. 2015 Oct;70(10):2763-9
pubmed: 26142410
J Antimicrob Chemother. 2016 Aug;71(8):2125-30
pubmed: 27494832
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29618504
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
J Antimicrob Chemother. 2018 Nov 1;73(11):3039-3043
pubmed: 30053018
Braz J Infect Dis. 2017 Nov - Dec;21(6):627-637
pubmed: 28941394
Enferm Infecc Microbiol Clin. 2009 Nov;27(9):503-10
pubmed: 19329230
J Clin Microbiol. 1988 Nov;26(11):2465-6
pubmed: 3069867
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29263073
Microb Genom. 2016 Dec 12;2(12):e000102
pubmed: 28348840
Ann N Y Acad Sci. 2017 Jan;1388(1):108-120
pubmed: 28134443